Author/Editor		Košnik, Mitja
Title		Zdravljenje KOPB z bronhodilatatorji
Translated title		Bronchodilatator treatment of COPD
Type		članek
Source		In: Šorli J, editor. Zbornik predavanj Obravnava bolnika s KOPB (predlogi za nacionalna priporočila); 1997 jun 13-14; Portorož. Ljubljana: Pnevmološka sekcija Slovenskega zdravniškega društva,
Publication year		1997
Volume		str. 70-5
Language		slo
Abstract		Because airflow obstruction in COPD is partially reversible, aggressive bronchodilator treatment is appropriate. Bronchodilator treatment in COPD is only symptomatic. it diminishes breathlessness, improves exercies tolerance and enhances quality of life but doesn't change the natural course of the disease. Except in mild disease inhaled bronchodilators should be used on regular basis and not "as needed". Ipratropium bromide is the treatment of choice because it has a pronounced bronchodilator effect and apparently no side effects. Treatment should begin with a single inhaled broncodilator. A bronchodilator potency of combination of ipratropium bromide and beta agonist is greater than the potency of a single drug. Bronchodilator treatment of COPD should follow the ERS statements.
Descriptors		LUNG DISEASES, OBSTRUCTIVE BRONCHODILATOR AGENTS